Résumé
Déf.: Insertion d’une aiguille dans la cavité pleurale afin d’évacuer le liquide pleural.
Preview
Unable to display preview. Download preview PDF.
Réf.
Antunes G, Neville E. Management of malignant pleural effusions. Thorax 2000;55:981–983
Bass J, White DA. Thoracocentesis in patients with hematologic malignancy: yield and safely. Chest 2005;127:2101–2105
Erasmus JJ, Goodman PC, Patz EF. Management of malignant pleural effusions and pneumothorax. Radiol Clin North Am 2000;38:375–383
Ferrer J, Roldan J. Clinical management of the patient with pleural effusion. Eur J Radiol 2000;34:76–86
Tassi GF, Cardillo G, Marchetti GP et al. Diagnostic and therapeutic management of malignant pleural effusion. Ann Oncol 2006;17(suppl 2):ii11–12
Réf.
Antony VB, Loddenkemper R, Astoul P et al. Management of malignant pleural effusions. Eur Respir J 2001;18:402–419
Antunes G, Neville E. Management of malignant pleural effusions. Thorax 2000;55:981–983
Dikensoy O, Light RW. Alternative widely available, inexpensive agents for pleurodesis. Curr Opin Pulm Med2005;11:340–344
Janssen JP, Collier G, Astoul P et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: aprospective cohort study. Lancet 2007;369:1535–1539
Pollak JS. Malignant pleural effusions: treatment with tunneled long-term drainage catheters. Curr Opin Pulm Med 2002;8:302–307
Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004;CD002916
West SD, Davies RJ, Lee YC. Pleurodesis for malignant pleural effusions. Curr Opin Pulm Med 2004;10:305–310
Réf.
Adam RA, Adam YG. Malignant ascites. J Am Coll Surg 2004;198:999–1011
Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 2006;42:589–597
Covey AM. Management of malignant pleural effusions and ascites. J Support Oncol 2005;3:169–173
Parsons SL, Watson SA, Steele RJ. Malignant ascites. Br J Surg 1996;83:6–14
Runyon BA. Care of patients with ascites. N Engl J Med 1994;330:337–342
Réf.
Bain BJ. Bone marrow biopsy morbidity and mortality. Br J Haematol 2003;121:949–951
Eikelboom JW. Bone marrow biopsy in cytopenic or anticoagulated patients. Br J Haematol 2005;129:562–563
Hodges A, Koury MJ. Needle aspiration and biopsy in the diagnosis and monitoring of bone marrow diseases. Clin Lab Sci 1996;9:349–353
Hyun BH, Stevenson AJ, Hanau CA. Fundamentals of bone marrow examination. Hematol Oncol Clin North Am 1994;8:651–663
Parapia LA. Trepanning or threphines: a history of bone marrow biopsy. Br J Haematol 2007;139:14–19
Wang J, Weiss LM, Chang KL et al. Diagnostic utility of bilateral bone marrow examination. Cancer 2002;94:1522
Réf.
Bain BJ. Diagnosis from the blood smear. N Engl J Med 2005;353:498–507
Gulati GL, Hyun BH. Blood smear examination. Hematol Oncol Clin North Am 1994;8:631–650
Riley RS, Hogan TF, Pavot DR et al. Performing a bone marrow examination. J Clin Lab Anal 2004;18:70–90
Réf.
Blaney SM, Poplack DG. New cytotoxic drugs for intrathecal administration. J Neurooncol 1998;38:219–223
Chamberlain MC. Neoplastic meningitis. J Clin Oncol 2005;23:3605–3613
Mercadante S. Controversies over spinal treatment in advanced cancer patients. Support Care Cancer 1998;6:495–502
Roos KL. Lumbar puncture. Semin Neurol 2003;23:105–114
Réf.
Boersma RS, Jie KSG Verbon A et al. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 2008;19:433–442
Freytes CO. Indications and complications of intravenous devices for chemotherapy. Curr Opin Oncol 2000;12:303–307
Higgs ZJC, Macafee DAL, Braithwaite BD et al. The Seldinger technique: 50 years on. Lancet 2005;366:1407–1409
Kuter DJ. Thrombolic complications of central venous catheters in patients. Oncologist 2004;9:207–216
Lee AY, Levine MN, Butler G et al. Incidence, risk factors and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006;24:1404–1408
Lubelcheck RJ, Weinstein RA. Strategies for preventing catheter-related bloodstream infections: the role of new technologies. Crit Care Med 2006;34:905–907
Vescia S, Baumgärtner AK, Jacobs VR et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol 2008;19:9–15
Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003;21:3665–3675
Réf.
Chien JW. Making the most of blood cultures. Tips for optimal use of this time-honored test. Postgrad Med 1998;104:119–124, 127
De Marie S. New developments in the diagnosis and management of invasive fungal infections. Haematologica 2000;85:88–93
Lamy B, Roy P, Carret G et al. What is the relevance of obtaining multiple blood samples for culture? A comprehensive model to optimize the strategy for diagnosing bacteremia. Clin Infect Dis 2002;35:842–850
Mylotte JM, Tayara A. Blood cultures: clinical aspects and controversies. Eur J Clin Microbiol Infect Dis 2000;19:157–163
Weinstein MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis 1996;23:40–46
Rights and permissions
Copyright information
© 2011 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Engelhardt, R., Engelhardt, A., Gärtner, F., Mielke, S., Frank, U., Bertz, H. (2011). Procédures opérationnelles standards (POS). In: Précis d’hématologie et d’oncologie. Springer, Paris. https://doi.org/10.1007/978-2-287-99342-8_10
Download citation
DOI: https://doi.org/10.1007/978-2-287-99342-8_10
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-99341-1
Online ISBN: 978-2-287-99342-8